Bold Capital Select

Bold Capital Select is a venture capital fund managed by Bold Capital Partners, which was founded in 2015 and is based in Santa Monica, California. The fund focuses on early-stage investments primarily in technology companies across various sectors, including communications, education, healthcare, artificial intelligence, and digital health, among others. With a commitment to fostering innovation, Bold Capital Select aims to support companies that are poised for exponential transformation within their respective industries. The firm's investment strategy reflects a broad interest in advanced technologies and their applications, positioning it to capitalize on emerging trends in the market.

Will Borthwick Jr.

Principal

Teymour Boutros-Gali

Managing Partner

Teymour Boutros-Ghali

Managing Partner

Felicia Hsu

Principal

Neil Jacobstein

Venture Partner

William Meeker

CFO

Henry Shi Ph.D

Venture Partner

Ysette Witteveen

Investment Partner

Mignon Xu

Associate

Helen McBride Ph.D

Operating Partner

76 past transactions

Solarea Bio

Series B in 2023
Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.

Dreamscape Learn

Series A in 2023
Dreamscape Learn is an edtech company focusing on cinematic story-telling, cutting-edge immersive technologies, and advanced pedagogy. They believe that the best educational designs combine multiple pedagogical modalities. Students study; they apply knowledge and concepts; they learn by doing and do in order to learn; they learn through text, lecture, visual and audio media, hands-on experience, and from one another. They create programs and products that connect all of these modes of engagement.

Deciduous Therapeutics

Seed Round in 2022
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune-modulatory therapies that clear senescent cells and promote a healthy lifespan. Deciduous is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, a five-time biotech founder.

KeyCare

Series A in 2022
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

AliveCor

Series F in 2022
AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.

InSilico Medicine

Series D in 2022
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.

Curebase

Series B in 2022
Curebase is a software company that specializes in digital solutions for clinical trials, aiming to transform how medical providers manage these studies. Established in 2017 and based in San Francisco, California, the company offers a platform that streamlines various aspects of clinical trial execution, including participant eligibility, enrollment, education, and consent. By automating manual processes and facilitating trial distribution to clinics, Curebase significantly reduces recruitment times and overall costs associated with conducting clinical trials. Its services cater to medical device, biotech, and digital health startups, providing sponsors with essential data access to monitor trial progress effectively.

Crowdz

Convertible Note in 2022
Crowdz provides invoice-financing opportunities to companies in global supply chains—a $9 trillion market that SMEs traditionally have been excluded from. The need for such financing is greater than ever before. Some 93% of all supply-chain participants are SMEs, and half of these suffer cashflow shortages as they wait for 90 to 120 days or more to be paid. Crowdz’s global invoice auction solves this problem by directing competitive, low-cost financing to SMEs while offering high returns to funders seeking better investments.

Verana Networks

Series B in 2022
Verana Networks develops an innovative 5G Radio Access Network solution for service providers that have licensed millimeter wave (mmWave) spectrum. The company focuses on enabling 5G in mmWave spectrum because that is where the largest amount of new spectrum is. For 5G to succeed, it must deliver a 10X-50X increase in speed and capacity. Blazing fast speed and an increase in capacity enable new applications, these new applications create incremental revenue, and incremental revenue is essential to support the business case for 5G.

Rugged Robotics

Series A in 2022
Rugged Robotics Inc. designs and develops robotic platforms for commercial construction industries. The company was founded in 2018 and is based in Houston, Texas.

ParkourSC

Venture Round in 2022
Cloudleaf, Inc. is a technology company based in Milpitas, California, specializing in location-aware sensory platforms for industries such as automotive, aerospace, pharmaceuticals, life sciences, and industrial manufacturing. Founded in 2014, the company offers CloudOS, a cloud-based platform that provides centralized visibility and management of sensory and connector devices. Its product line includes the Cloudleaf Sensor, which collects location and asset-level information using Bluetooth Smart technology, the Cloudleaf Zone Sensor for managing entry and exit events in critical workflow areas, and the Cloudleaf Gateway that facilitates communication between sensors and the cloud. Additionally, Cloudleaf provides solutions for supply chain visibility, work-in-progress monitoring, condition monitoring, and preventative maintenance. The company's platform creates a digital twin of the supply chain, processing billions of events per second to deliver real-time insights on location, condition, utilization, and anomaly detection.

Gameto

Series A in 2022
Gameto is a biotechnology company focused on addressing infertility and menopause-related challenges. Founded in 2020 and headquartered in New York, the firm employs a unique platform that utilizes proprietary combinations of transcription factors to create engineered ovarian cell lines. These cell lines are designed to replicate the functions of natural ovarian cells, allowing for the production and regulation of hormones essential for female reproductive health. By harnessing allogeneic human cellular derivatives, Gameto aims to develop therapeutic applications that can effectively treat conditions associated with accelerated ovarian aging and enhance assisted fertility options for women.

Viome

Series C in 2021
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.

MagicCube

Series C in 2021
MagicCube, Inc. is a technology company based in Sunnyvale, California, founded in 2014. The company focuses on securing data exchange between devices and the cloud, primarily targeting mobile applications that handle sensitive user data, such as banking and shopping apps. Its platform, which utilizes Software Defined Trust (SDT) and TEE-based technology, offers device-independent security solutions that protect against various forms of attacks, including those on devices, in the cloud, and across networks. By embedding its software into existing applications, MagicCube enables secure digital transactions across a wide range of devices and operating systems, facilitating large-scale deployment and management of IoT and mobile security solutions.

Meru Health

Series B in 2021
Meru Health, Inc. develops an application that connects patients to licensed therapists for a 12-week program to treat people experiencing stress, depression, anxiety, and other mental health issues. The company provides a licensed-clinician-supported, mobile phone-based digital therapeutic program for depression and anxiety. The company was founded in 2016 and is based in San Mateo, California. It has additional offices in Palo Alto, California and Helsinki, Finland.

Elevian

Series A in 2021
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company is focused on developing therapeutics aimed at restoring regenerative capacity to prevent and treat age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscles. The company's therapeutic candidates target the root causes of aging and aim to address conditions such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. By identifying and regulating blood factors that influence aging, Elevian seeks to enable effective treatments that enhance the body’s natural repair and regeneration mechanisms.

Curebase

Series A in 2021
Curebase is a software company that specializes in digital solutions for clinical trials, aiming to transform how medical providers manage these studies. Established in 2017 and based in San Francisco, California, the company offers a platform that streamlines various aspects of clinical trial execution, including participant eligibility, enrollment, education, and consent. By automating manual processes and facilitating trial distribution to clinics, Curebase significantly reduces recruitment times and overall costs associated with conducting clinical trials. Its services cater to medical device, biotech, and digital health startups, providing sponsors with essential data access to monitor trial progress effectively.

Docbot

Series A in 2021
DocBot, Inc. is a technology company based in Irvine, California, that develops web-based applications for iOS and Android devices. The company's offerings include a clinical decision support system and cloud analytics, which aggregate patient information to assist physicians and specialists in delivering improved care. Additionally, DocBot has created an image analysis platform specifically designed to aid in the detection of colorectal cancer and gastrointestinal diseases. This platform integrates various data sources, including imaging systems and pathology requisitions, enabling healthcare providers to enhance patient outcomes while reducing cancer risk. Through its commitment to intuitive software design, DocBot aims to empower physicians in their clinical decision-making processes.

SeQure DX

Venture Round in 2021
SeQure DX is in the business activities at non-commercial site business. It was founded in 2020 and is based in Waltham, Massachusetts.

Bionaut Labs

Series A in 2021
Bionaut Labs is a biotechnology company that specializes in developing an intra-tissue navigation platform using nano and micro-robots for medical applications. Founded in 2016 and headquartered in California, Bionaut Labs focuses on creating a delivery mechanism that allows for anatomically precise navigation within the body. The company's innovative micro-robotic technology is designed to access any anatomical location, enabling medical professionals to perform complex surgical procedures remotely and without external incisions. This advancement is achieved through an advanced remote control and imaging system that accurately guides the robots to their targets, monitors their progress, and triggers the release of therapeutic payloads at the appropriate locations and times.

Mighty Buildings

Series B in 2021
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of custom houses using 3D printing technology. The company aims to disrupt the residential housing market by leveraging advanced automation, robotics, and composite materials to make housing more affordable. By focusing on modular construction, Mighty Buildings seeks to innovate the way homes are built, addressing challenges in the traditional construction industry. The company has garnered support from notable venture capital firms, reflecting its potential to transform the housing landscape.

Crowdz

Series A in 2020
Crowdz provides invoice-financing opportunities to companies in global supply chains—a $9 trillion market that SMEs traditionally have been excluded from. The need for such financing is greater than ever before. Some 93% of all supply-chain participants are SMEs, and half of these suffer cashflow shortages as they wait for 90 to 120 days or more to be paid. Crowdz’s global invoice auction solves this problem by directing competitive, low-cost financing to SMEs while offering high returns to funders seeking better investments.

Elevian

Venture Round in 2020
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company is focused on developing therapeutics aimed at restoring regenerative capacity to prevent and treat age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscles. The company's therapeutic candidates target the root causes of aging and aim to address conditions such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. By identifying and regulating blood factors that influence aging, Elevian seeks to enable effective treatments that enhance the body’s natural repair and regeneration mechanisms.

AliveCor

Series E in 2020
AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.

Solarea Bio

Series A in 2020
Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.

Symbiome

Venture Round in 2020
Symbiome, Inc. is a skincare company based in San Francisco, California, specializing in products formulated with microbiomic and plant-based ingredients. Founded in 2017, the company aims to provide skincare solutions that reflect natural principles and utilize ancestral ingredients. Originally known as Persona Biome, Inc., it adopted the name Symbiome, Inc. in December 2019. By combining scientific research with traditional knowledge, Symbiome develops products designed to promote healthy skin.

Deep Longevity

Series A in 2020
Deep Longevity, Inc. is a biotechnology company focused on advancing the field of aging and longevity through the development of innovative biomarkers and predictive tools. Established in 2016 and headquartered in Hong Kong, the company creates aging clocks and biomarker platforms that utilize various data types, including clinical blood tests, transcriptomic, proteomic, and epigenetic data. Its offerings include Longevity Cloud, which hosts deep aging clocks, and Young.AI, an application designed for tracking biological age and providing recommendations for longevity interventions. Additionally, Deep Longevity produces AgeMetric Reports to help users monitor their biological age over time. By leveraging artificial intelligence, the company aims to enable longevity clinics and healthcare providers to more accurately assess and improve individual health outcomes related to aging.

Crowdz

Series A in 2020
Crowdz provides invoice-financing opportunities to companies in global supply chains—a $9 trillion market that SMEs traditionally have been excluded from. The need for such financing is greater than ever before. Some 93% of all supply-chain participants are SMEs, and half of these suffer cashflow shortages as they wait for 90 to 120 days or more to be paid. Crowdz’s global invoice auction solves this problem by directing competitive, low-cost financing to SMEs while offering high returns to funders seeking better investments.

Proprio

Series A in 2020
Proprio, Inc. is a Seattle-based healthcare technology company founded in 2016, specializing in next-generation surgical navigation and imaging solutions. The company develops a platform that integrates machine learning, automated intelligence, and mixed-reality user interfaces to enhance surgical accuracy and streamline workflows. By utilizing advanced technologies such as light field computer vision and depth-sensing capabilities, Proprio's system replaces traditional surgical microscopes, navigation systems, and loupes, offering a more immersive 3D environment for medical professionals. This innovative approach aims to improve patient outcomes while allowing for greater adaptability in surgical practices. Proprio's vision extends beyond mere technological upgrades; the company seeks to revolutionize the medical field by harnessing software development techniques, thereby enabling rapid innovation and a more integrated use of data and artificial intelligence in surgery.

MagicCube

Series B in 2020
MagicCube, Inc. is a technology company based in Sunnyvale, California, founded in 2014. The company focuses on securing data exchange between devices and the cloud, primarily targeting mobile applications that handle sensitive user data, such as banking and shopping apps. Its platform, which utilizes Software Defined Trust (SDT) and TEE-based technology, offers device-independent security solutions that protect against various forms of attacks, including those on devices, in the cloud, and across networks. By embedding its software into existing applications, MagicCube enables secure digital transactions across a wide range of devices and operating systems, facilitating large-scale deployment and management of IoT and mobile security solutions.

Meru Health

Series A in 2020
Meru Health, Inc. develops an application that connects patients to licensed therapists for a 12-week program to treat people experiencing stress, depression, anxiety, and other mental health issues. The company provides a licensed-clinician-supported, mobile phone-based digital therapeutic program for depression and anxiety. The company was founded in 2016 and is based in San Mateo, California. It has additional offices in Palo Alto, California and Helsinki, Finland.

Pyka

Seed Round in 2019
Pyka, Inc. specializes in the development of autonomous electric aircraft, primarily aimed at the agricultural sector. Founded in 2016 and headquartered in Oakland, California, the company creates aircraft designed for the application and spraying of chemicals on agricultural lands. These planes are equipped with advanced technology, including autonomous flight controllers, onboard sensors, and systems for obstacle detection and path planning. This enables them to navigate various terrains and perform hyper-short takeoffs and landings from nearly any location. Pyka's aircraft are notable for being the first certified electric autonomous airplanes to operate commercially, providing an innovative and efficient alternative to traditional ground transit in agriculture.

Pyka

Seed Round in 2019
Pyka, Inc. specializes in the development of autonomous electric aircraft, primarily aimed at the agricultural sector. Founded in 2016 and headquartered in Oakland, California, the company creates aircraft designed for the application and spraying of chemicals on agricultural lands. These planes are equipped with advanced technology, including autonomous flight controllers, onboard sensors, and systems for obstacle detection and path planning. This enables them to navigate various terrains and perform hyper-short takeoffs and landings from nearly any location. Pyka's aircraft are notable for being the first certified electric autonomous airplanes to operate commercially, providing an innovative and efficient alternative to traditional ground transit in agriculture.

GuRu

Series A in 2019
GuRu Wireless, Inc. makes wireless power products that just work – no training required. The company uses millimeter-wave (mmWave) technology to deliver electric power through the air nearly as fast as over wires to multiple devices simultaneously. GuRu’s products are safe, easy to use, and intelligent – automatically finding and adjusting power levels for any device. Founded by a team of Caltech electrical engineers, applied physicists, and integrated circuit and phased array experts, GuRu is based in Pasadena, Calif.

Metawave

Series A in 2019
Metawave Corporation, founded in 2017 and based in Palo Alto, California, develops innovative beamsteering radar technologies using metamaterials and artificial intelligence for the automotive industry and transportation providers. The company’s flagship product, SPEKTRA, enhances safety for automated driving by providing advanced radar capabilities, including 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave offers TURBO active repeaters to improve signal coverage in challenging environments and ECHO passive reflectors that effectively direct signals in areas with lower coverage. The company also features the AWARE AI platform, which utilizes deep learning to derive meaningful insights from radar signals. Alongside its automotive focus, Metawave is working on smart beamsteering antennas designed to enhance 4G and 5G networks, aiming to deliver faster connectivity for a wide range of users.

InSilico Medicine

Series B in 2019
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.

InSilico Medicine

Series B in 2019
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.

ParkourSC

Series B in 2019
Cloudleaf, Inc. is a technology company based in Milpitas, California, specializing in location-aware sensory platforms for industries such as automotive, aerospace, pharmaceuticals, life sciences, and industrial manufacturing. Founded in 2014, the company offers CloudOS, a cloud-based platform that provides centralized visibility and management of sensory and connector devices. Its product line includes the Cloudleaf Sensor, which collects location and asset-level information using Bluetooth Smart technology, the Cloudleaf Zone Sensor for managing entry and exit events in critical workflow areas, and the Cloudleaf Gateway that facilitates communication between sensors and the cloud. Additionally, Cloudleaf provides solutions for supply chain visibility, work-in-progress monitoring, condition monitoring, and preventative maintenance. The company's platform creates a digital twin of the supply chain, processing billions of events per second to deliver real-time insights on location, condition, utilization, and anomaly detection.

Mighty Buildings

Series A in 2019
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of custom houses using 3D printing technology. The company aims to disrupt the residential housing market by leveraging advanced automation, robotics, and composite materials to make housing more affordable. By focusing on modular construction, Mighty Buildings seeks to innovate the way homes are built, addressing challenges in the traditional construction industry. The company has garnered support from notable venture capital firms, reflecting its potential to transform the housing landscape.

Gallant

Series A in 2019
Gallant Pet, Inc. is a pet service company that specializes in stem cell preservation and therapy for dogs. Founded in 2018 and based in San Diego, California, the company collects and banks stem cells from pets during routine spay or neuter procedures. It provides a platelet-rich plasma (PRP) kit for treating dogs suffering from conditions like osteoarthritis and other musculoskeletal issues. Gallant Pet also engages in clinical research to develop effective stem cell therapies, aiming to utilize a pet's natural biology to treat future health problems while minimizing the need for traditional medications and surgeries. This approach allows pet owners to preserve their pets' young stem cells for potential future treatments.

Gali Health

Seed Round in 2019
Gali Health, Inc. is a health technology company based in San Francisco, California, established in 2015. The company focuses on developing a mobile application named Gali, which serves as a personal health assistant designed to support individuals with chronic conditions. By leveraging collective intelligence, Gali enables users to proactively manage their health through crowdsourced personal health data and medically-validated insights. The application employs artificial intelligence to provide highly personalized support, addressing medical, lifestyle, and psychological aspects of living with chronic diseases. Gali Health aims to empower users by ensuring they do not feel isolated or powerless in managing their health, advancing consumer-driven healthcare through innovative technology and personalized health tracking.

Viome

Series B in 2019
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.

Mojo Vision

Series B in 2019
Mojo Vision is a company based in Saratoga, California, that specializes in augmented reality products and platforms. Founded in 2015, it has developed a smart contact lens featuring a built-in display that provides timely information without disrupting the user's focus. This innovative technology enables users to receive immediate and relevant information, facilitating hands-free communication and interaction. By minimizing the distractions associated with traditional mobile devices, Mojo Vision aims to enhance connectivity and accessibility for users in various environments.

Docbot

Seed Round in 2019
DocBot, Inc. is a technology company based in Irvine, California, that develops web-based applications for iOS and Android devices. The company's offerings include a clinical decision support system and cloud analytics, which aggregate patient information to assist physicians and specialists in delivering improved care. Additionally, DocBot has created an image analysis platform specifically designed to aid in the detection of colorectal cancer and gastrointestinal diseases. This platform integrates various data sources, including imaging systems and pathology requisitions, enabling healthcare providers to enhance patient outcomes while reducing cancer risk. Through its commitment to intuitive software design, DocBot aims to empower physicians in their clinical decision-making processes.

Iota Biosciences

Series A in 2018
Iota Biosciences, Inc. is a medical device company based in Berkeley, California, founded in 2017. The company specializes in developing wireless sensors and devices that monitor, measure, and stimulate internal nerves, muscles, and organs for electroceutical applications, particularly in the treatment of immune and neural disorders. Iota Biosciences has pioneered a neural dust technology that employs implantable, mote-sized ultrasonic sensors, allowing for completely wireless and untethered neural recordings in the brain. This innovation eliminates the need for invasive wiring through the skull, enabling real-time wireless cortical recording and improving the monitoring and treatment of various diseases. As of late 2020, Iota Biosciences operates as a subsidiary of Astellas Pharma Inc.

Octi

Seed Round in 2018
Octi: The first people-powered social AR platform.

InSilico Medicine

Series A in 2018
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.

Oura

Series A in 2018
Oura is a pioneering sleep performance platform, focused on improving sleep that leads to a better life. The Oura Ring and app gives users daily feedback to improve their health, allowing users to better understand their body and reach their goals. Oura Health OyLtd. is a health technology company founded in Oulu, Finland in 2013. In 2018, the company received the Red Dot Awards for communications design and product design. Backed by world-class investors, leaders, champions, and creators, Oura Health is based in Oulu & Helsinki, Finland, and San Francisco, California.

IVIVA

Seed Round in 2018
IVIVA Medical, Inc. develops bio-artificial platforms and systems to provide therapies. It develops alternative end-state renal disease therapies that alleviate donor organ demand for patients; disease and pathology modeling; and bioreactor systems. The company was incorporated in 2013 and is based in Beverly, Massachusetts.

Synadia

Seed Round in 2018
Synadia Communications Inc. is a technology company based in Los Angeles, California, founded in 2017. It specializes in developing a global utility platform designed to connect various digital systems, services, and devices. The company's primary product is NATS.io, an open-source messaging system tailored for cloud-native applications, Internet of Things (IoT) messaging, and microservices architectures. As the leader in the development of NATS.io, which is recognized as a Cloud Native Computing Foundation (CNCF) project, Synadia also offers a secure and globally available communications platform known as NGS. In addition to its core offerings, the company provides commercial support, consulting services, non-recurring engineering (NRE), and training to its clients.

Elevian

Convertible Note in 2018
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company is focused on developing therapeutics aimed at restoring regenerative capacity to prevent and treat age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscles. The company's therapeutic candidates target the root causes of aging and aim to address conditions such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. By identifying and regulating blood factors that influence aging, Elevian seeks to enable effective treatments that enhance the body’s natural repair and regeneration mechanisms.

Exo

Series A in 2017
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.

Atomiton

Seed Round in 2017
Atomiton is a software company that specializes in developing a platform aimed at transforming and optimizing industrial operations globally. Its innovative technology focuses on smart systems, particularly in the realm of the Internet of Things. By leveraging artificial intelligence and machine learning, Atomiton's platform enhances operational efficiencies, facilitates real-time industrial analytics, and provides sustainability metrics. This enables businesses to achieve cost reductions while minimizing their operational energy, water, and carbon intensity. Through its solutions, Atomiton supports companies in their efforts to improve performance and reduce their environmental impact.

Dreamscape Immersive

Series B in 2017
Dreamscape Immersive, Inc. specializes in location-based virtual reality entertainment, offering innovative experiences that blend cinematic storytelling with the excitement of theme parks. Founded in 2016 and headquartered in Culver City, California, the company has developed a platform called Dreamscape, designed to deliver immersive narratives that can be enjoyed with family and friends. With locations in Los Angeles, Dallas, Columbus, and Dubai, Dreamscape provides audiences with access to both original content and franchised experiences, catering to a diverse range of VR enthusiasts. The company's approach aims to redefine mainstream entertainment by creating engaging and interactive environments.

ParkourSC

Series A in 2017
Cloudleaf, Inc. is a technology company based in Milpitas, California, specializing in location-aware sensory platforms for industries such as automotive, aerospace, pharmaceuticals, life sciences, and industrial manufacturing. Founded in 2014, the company offers CloudOS, a cloud-based platform that provides centralized visibility and management of sensory and connector devices. Its product line includes the Cloudleaf Sensor, which collects location and asset-level information using Bluetooth Smart technology, the Cloudleaf Zone Sensor for managing entry and exit events in critical workflow areas, and the Cloudleaf Gateway that facilitates communication between sensors and the cloud. Additionally, Cloudleaf provides solutions for supply chain visibility, work-in-progress monitoring, condition monitoring, and preventative maintenance. The company's platform creates a digital twin of the supply chain, processing billions of events per second to deliver real-time insights on location, condition, utilization, and anomaly detection.

GuRu

Seed Round in 2017
GuRu Wireless, Inc. makes wireless power products that just work – no training required. The company uses millimeter-wave (mmWave) technology to deliver electric power through the air nearly as fast as over wires to multiple devices simultaneously. GuRu’s products are safe, easy to use, and intelligent – automatically finding and adjusting power levels for any device. Founded by a team of Caltech electrical engineers, applied physicists, and integrated circuit and phased array experts, GuRu is based in Pasadena, Calif.

Metawave

Seed Round in 2017
Metawave Corporation, founded in 2017 and based in Palo Alto, California, develops innovative beamsteering radar technologies using metamaterials and artificial intelligence for the automotive industry and transportation providers. The company’s flagship product, SPEKTRA, enhances safety for automated driving by providing advanced radar capabilities, including 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave offers TURBO active repeaters to improve signal coverage in challenging environments and ECHO passive reflectors that effectively direct signals in areas with lower coverage. The company also features the AWARE AI platform, which utilizes deep learning to derive meaningful insights from radar signals. Alongside its automotive focus, Metawave is working on smart beamsteering antennas designed to enhance 4G and 5G networks, aiming to deliver faster connectivity for a wide range of users.

MagicCube

Series A in 2017
MagicCube, Inc. is a technology company based in Sunnyvale, California, founded in 2014. The company focuses on securing data exchange between devices and the cloud, primarily targeting mobile applications that handle sensitive user data, such as banking and shopping apps. Its platform, which utilizes Software Defined Trust (SDT) and TEE-based technology, offers device-independent security solutions that protect against various forms of attacks, including those on devices, in the cloud, and across networks. By embedding its software into existing applications, MagicCube enables secure digital transactions across a wide range of devices and operating systems, facilitating large-scale deployment and management of IoT and mobile security solutions.

Viome

Series A in 2017
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.

Exo

Venture Round in 2017
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.

Dreamscape Immersive

Series A in 2017
Dreamscape Immersive, Inc. specializes in location-based virtual reality entertainment, offering innovative experiences that blend cinematic storytelling with the excitement of theme parks. Founded in 2016 and headquartered in Culver City, California, the company has developed a platform called Dreamscape, designed to deliver immersive narratives that can be enjoyed with family and friends. With locations in Los Angeles, Dallas, Columbus, and Dubai, Dreamscape provides audiences with access to both original content and franchised experiences, catering to a diverse range of VR enthusiasts. The company's approach aims to redefine mainstream entertainment by creating engaging and interactive environments.

DigiLens

Series B in 2017
DigiLens Inc. is a developer and manufacturer of optical platform and photopolymer technology solutions specializing in waveguide displays for extended reality (XR) applications. The company offers a range of products, including the Crystal30 and Crystal50 lenses, which enable original equipment manufacturers (OEMs) to create customizable XR devices for both enterprise and consumer markets. DigiLens also provides innovative solutions like the DigiLens AutoHUD, which enhances the field of view and reduces component size in heads-up displays, and CrystalClear, an augmented reality heads-up display. In addition to display technologies, DigiLens supplies light engines and hardware development kits, such as Insight30, which assist users in evaluating and developing wearable devices. Founded in 1997 and based in Sunnyvale, California, DigiLens has positioned itself as a leader in holographic waveguide technology, enabling various industries, including automotive, enterprise, consumer, avionics, and military, to leverage XR capabilities.

Terramera

Venture Round in 2016
Terramera, Inc. is a Canadian company based in Vancouver, founded in 2009, that specializes in developing and manufacturing plant-based pesticides and fertilizers. The company utilizes green chemistry, machine learning, and artificial intelligence to create safer and more effective alternatives to synthetic chemical products. Its product line includes Proof, a solution for eliminating bed bugs and dust mites; Actigate, an organic pesticide; and Rango, a pest control and crop protection product. Terramera's mission is to harness technology to unlock the power of nature, promoting healthier living and making clean food more accessible. The company aims to cultivate safe environments and enhance agricultural practices by providing farmers and growers with sustainable solutions that improve yields while minimizing the use of toxic chemicals.

Epharmix

Seed Round in 2016
Epharmix, Inc. is a digital healthcare company that specializes in developing clinically validated, condition-specific communication tools for the healthcare industry. Founded in 2015 and based in Saint Louis, Missouri, Epharmix provides digital interventions designed to enhance patient-physician engagement, automate the collection of clinical data, and alert healthcare providers for effective chronic care management. Its products aim to improve care for underserved patients while also reducing the workload of care teams, ultimately enhancing patient engagement and health outcomes.

Meta View

Series B in 2016
Meta View is a technology company specializing in augmented and virtual reality solutions, catering to various industries such as manufacturing, communication, media, medicine, education, and 3D modeling. Founded in 2019 by Ben Sand, Meron Gribetz, and Raymond Lo, the company develops wearable devices and development kits, including the Meta 1 and Meta 2, which enable users to interact with holograms and access digital information seamlessly. Headquartered in San Mateo, California, Meta View distributes its products to markets in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Singapore, Taiwan, and throughout the European Union and EFTA. The company's innovative offerings leverage machine learning and artificial intelligence to enhance user experiences in both augmented and virtual reality environments.

Terramera

Venture Round in 2016
Terramera, Inc. is a Canadian company based in Vancouver, founded in 2009, that specializes in developing and manufacturing plant-based pesticides and fertilizers. The company utilizes green chemistry, machine learning, and artificial intelligence to create safer and more effective alternatives to synthetic chemical products. Its product line includes Proof, a solution for eliminating bed bugs and dust mites; Actigate, an organic pesticide; and Rango, a pest control and crop protection product. Terramera's mission is to harness technology to unlock the power of nature, promoting healthier living and making clean food more accessible. The company aims to cultivate safe environments and enhance agricultural practices by providing farmers and growers with sustainable solutions that improve yields while minimizing the use of toxic chemicals.

Singularity

Series A in 2016
Singularity University, founded in 2008 and based in Santa Clara, California, operates as a learning and innovation community that connects individuals, businesses, governments, and academic institutions to explore and utilize cutting-edge technologies. The organization offers a variety of educational programs, including executive courses, startup accelerators, and summits focused on topics like artificial intelligence, robotics, biotechnology, and digital fabrication. Its initiatives aim to address global challenges such as education, health, energy, and environmental sustainability, providing participants with the tools and insights necessary to implement impactful solutions. Singularity University also fosters a collaborative platform for networking and innovation, featuring a global presence with numerous campuses, summits, and a significant alumni network. Through its programs, the organization seeks to empower a diverse range of stakeholders to harness exponential technologies for positive societal change.

BlueLine Grid

Venture Round in 2016
BlueLine Grid operates the nation’s premier, trusted collaboration network for law enforcement, first responders, security teams, and corporations. BlueLine Grid provides an encrypted suite of messaging, voice, location, conferencing, virtual command, and file-sharing tools dedicated to the needs of public and private security officials, connecting teams internally and with each other on any device. BlueLine Grid was founded in 2013 and is headquartered in Annapolis, Maryland.

BlueDot

Venture Round in 2016
BlueDot's mission is to identify the most promising technological innovations at NASA & National labs and supercharge them with great entrepreneurs to tackle humanity’s grand challenges. We believe that nurturing cutting-edge research is an attractive, yet under-developed market segment that has yet to be explored by entrepreneurs. We identify radical technological breakthroughs and foster them to create companies that have the potential to improve the lives of billions around the world. Our proven entrepreneurial skills coupled with break through scientific research and unique insight of market trends is the heart of our competitive advantage.

CloudMondo

Venture Round in 2016
CloudMondo is a technology startup based in Silicon Valley, operating in stealth mode and led by an experienced executive team. The company has quickly advanced from concept to generating customer revenue within 20 months. CloudMondo aims to make internet connectivity a fundamental human right, akin to access to essential resources like water and healthcare. To achieve this, it has developed a patent-pending, AI-driven, cloud-based platform that significantly lowers the costs and complexities associated with delivering affordable broadband connectivity. This innovative platform is complemented by a suite of Over-The-Top (OTT) services designed for use by various entities, including venue owners, municipalities, and businesses, allowing them to provide interactive broadband access and generate revenue. CloudMondo's solution is already operational, serving customers across 12 countries and four continents.

Kindred AI

Series A in 2015
Kindred Systems, Inc. designs and develops artificial intelligence (AI) based robots to solve human problems. Its products include Kindred SORT, an AI powered robotic putwall solution that works with fulfillment center associates to assemble e-commerce orders from batch-picked items; and AutoGrasp, a robotic platform that controls robots to operate with human-like intelligence in dynamic environments. The company was founded in 2014 and is based in San Francisco, California with additional offices in Vancouver and Toronto, Canada.

Meta View

Series A in 2015
Meta View is a technology company specializing in augmented and virtual reality solutions, catering to various industries such as manufacturing, communication, media, medicine, education, and 3D modeling. Founded in 2019 by Ben Sand, Meron Gribetz, and Raymond Lo, the company develops wearable devices and development kits, including the Meta 1 and Meta 2, which enable users to interact with holograms and access digital information seamlessly. Headquartered in San Mateo, California, Meta View distributes its products to markets in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Singapore, Taiwan, and throughout the European Union and EFTA. The company's innovative offerings leverage machine learning and artificial intelligence to enhance user experiences in both augmented and virtual reality environments.

ParkourSC

Seed Round in 2014
Cloudleaf, Inc. is a technology company based in Milpitas, California, specializing in location-aware sensory platforms for industries such as automotive, aerospace, pharmaceuticals, life sciences, and industrial manufacturing. Founded in 2014, the company offers CloudOS, a cloud-based platform that provides centralized visibility and management of sensory and connector devices. Its product line includes the Cloudleaf Sensor, which collects location and asset-level information using Bluetooth Smart technology, the Cloudleaf Zone Sensor for managing entry and exit events in critical workflow areas, and the Cloudleaf Gateway that facilitates communication between sensors and the cloud. Additionally, Cloudleaf provides solutions for supply chain visibility, work-in-progress monitoring, condition monitoring, and preventative maintenance. The company's platform creates a digital twin of the supply chain, processing billions of events per second to deliver real-time insights on location, condition, utilization, and anomaly detection.

AliveCor

Series B in 2012
AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.